Skip to main contentSkip to footer
finger pointing scan
Brighton & Sussex Medical School

Our staff


BSMS > About BSMS > Contact us > Staff > Dr Collins Iwuji

Dr Collins C Iwuji

Collins iwuji2

Dr Collins Iwuji (MBBS, MSc, MD, MRCP)

Senior Lecturer in Sexual Health & HIV Medicine
E: c.iwuji@bsms.ac.uk
T: +44 (0)1273 872700
Location: Room 2.07 BSMS Teaching Building, University of Sussex, Falmer, Brighton, BN1 9PX

PA/DA: Debbie Miller
E: d.miller@bsms.ac.uk
T: +44(0)1273 877889

Areas of expertise: clinical outcomes on antiretroviral therapy; intervention trials; sexually transmitted Infections

Research areas: HIV prevention, Adherence, HIV drug resistance, HIV cascade of care

Other faculty positions: Honorary Consultant Physician in Sexual Health & HIV Medicine, Deputy Lead for Medical Students Clinical Elective module

BACKGROUND IMAGE FOR PANEL

Biography

Collins Iwuji is a Senior Lecturer in Sexual Health and HIV Medicine and an Honorary Consultant Physician at the Brighton and Sussex University Hospitals (BSUH). 

Collins obtained his medical degree from the Faculty of Medicine, Abia State University, Nigeria, followed by training in general internal in Birmingham. He completed his Specialist training in Sexual Health and HIV Medicine at BSUH, NHS Trust in 2011. Collins has an MSc in Epidemiology from the London School of Hygiene and Tropical Medicine, University of London. During his doctoral research at University College London, Collins investigated whether earlier treatment of HIV in rural South Africa will lead to drug resistance of the prevalence and form likely to make HIV elimination difficult.

Research

Collins has been involved in Global Health research in HIV since 2011 and has broad research interests on HIV treatment outcomes in resource-constrained settings and sexually transmitted infections. He is particularly interested in the use of ART for the prevention of sexual transmission of HIV having undertaken the first population-based clinical trial in the world evaluating the impact of ART on HIV incidence in rural South Africa. Currently active areas of research include ART adherence, HIV cascade of care, HIV drug resistance and the relationship between climate change and health in the context of achieving sustainable development goals.

BACKGROUND IMAGE FOR PANEL

Teaching

Collins teaches HIV medicine, sexual health and global health to undergraduate medical and MSc students. He also supervises dissertation for the MSc Global Health. He is the deputy lead for the medical students’ clinical elective module.

Selected publications

Iwuji CC, Orne-Gliemann J, Larmarange J, Balestre E, Thiebaut R, Tanser F, Okesola N, Makowa T, Dreyer J, Herbst K, McGrath N, Bärnighausen T, Boyer S, De Oliveira T, Rekacewicz C, Bazin B, Newell ML, Pillay D, Dabis F; ANRS 12249 TasP Study Group. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. Lancet HIV. 2017 Nov 30. pii: S2352-3018(17)30205-9. doi: 10.1016/S2352-3018(17)30205-9. [Epub ahead of print]

Iwuji C, Newell M-L (2017). Towards control of the global HIV epidemic: Addressing the middle-90 challenge in the UNAIDS 90–90–90 target. PLoS Med 14(5): e1002293. https://doi.org/10.1371/journal.pmed.1002293

Collier D, Iwuji C, Derache A, de Oliveira T, Okesola N, Calmy A, Dabis F, Pillay D, Gupta RK for the ANRS 12249 TasP Study Group. Virological outcomes of second-line protease inhibitor based treatment for HIV-1 in a high prevalence rural South African Setting: a competing risk prospective cohort analysis. Clin Infect Dis. 2017 Mar 13. doi: 10.1093/cid/cix015*

Iwuji CC, Orne-Gliemann J, Larmarange J, Okesola N, Tanser F, Thiebaut R, Rekacewicz C, Newell, ML, Dabis F for the ANRS 12249 TasP trial group. Uptake of home-based HIV testing, linkage to care, and community attitudes about ART in Rural KwaZulu-Natal, South Africa: descriptive results from the first phase of the ANRS 12249 TasP Cluster-Randomized Trial" PLoS Med 13(8): e1002107. doi:10.1371/journal.pmed.1002107 [link: PLoS Med. 2016 Aug 9;13(8):e1002107. doi: 10.1371/journal.pmed.1002107. eCollection 2016]

Boyer S, Iwuji C, Gosset A, Protopopescu, C, Okesola N, Plazy M, Larmarange J. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat program: early findings of the ANRS 12249 TasP trial in rural South Africa. AIDS Care 2016;28 Suppl 3:39-51. doi: 10.1080/09540121.2016.1164808 [link: AIDS Care. 2016;28 Suppl 3:39-51. doi: 10.1080/09540121.2016.1164808]

CE Oldenburg, T Bärnighausen, F Tanser, CC Iwuji, V De Gruttola, GR Seage, MJ Mimiaga,KH Mayer, D Pillay, G Harling. Antiretroviral therapy to prevent HIV acquisition in serodiscordant couples in a hyperendemic community in rural South Africa [link: Clin Infect Dis. 2016 Aug 15;63(4):548-54. doi: 10.1093/cid/ciw335. Epub 2016 May 20]

Iwuji CC, McGrath N, de Oliveira T, Porter K, Pillay D, Fisher M, Newport M, Newell ML. The Art of HIV Elimination: Past and Present Science [link: J AIDS Clin Res. 2015 Nov 30;6. pii: 525]

Iwuji, C.C., Orne-Gliemann, J., Tanser, F., Boyer, S., Lessells, R.J., Lert, F., Imrie, J., Bärnighausen, T., Rekacewicz, C., Bazin, B., Newell, M.L., Dabis, F., Okesola, N., Bland, R., de Oliveira, T., Viljoen, J., Newell, C., Naidu, K., Lert, F., Dray-Spira, R., Larmarange, J., Spire, B., Chaix, M.L., Karcher, S., Thiébaut, R., Freedberg, K. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (treatment as prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial [link: Trials. 2013 Jul 23; 14:230. doi: 10.1186/1745-6215-14-230]

Iwuji, C.C., Churchill, D., Gilleece, Y., Weiss, H.A., Fisher, M., Older HIV-infected individuals present late and have a higher mortality: Brighton, UK cohort study [link: BMC Public Health. 2013 Apr 26;13:397. doi: 10.1186/1471-2458-13-397]

Iwuji C.C., Mayanja, B.N., Weiss, H.A., Atuhumuza, E., Hughes, P., Maher, D., Grosskurth, H. Morbidity in HIV-1-infected individuals before and after the introduction of antiretroviral therapy: a longitudinal study of a population-based cohort in Uganda [link: HIV Med. 2011 Oct;12(9):553-61. doi: 10.1111/j.1468-1293.2011.00923.x. Epub 2011 Apr 27]